VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $312,000 | +49.3% | 13,405 | +2.3% | 0.00% | +50.0% |
| Q1 2018 | $209,000 | -24.3% | 13,102 | -1.3% | 0.00% | -33.3% |
| Q4 2017 | $276,000 | -45.9% | 13,276 | -62.7% | 0.00% | -57.1% |
| Q3 2017 | $510,000 | -26.1% | 35,580 | -10.8% | 0.01% | -30.0% |
| Q2 2017 | $690,000 | +34.5% | 39,866 | -14.3% | 0.01% | +11.1% |
| Q1 2017 | $513,000 | +45.3% | 46,538 | +246.2% | 0.01% | +12.5% |
| Q1 2016 | $353,000 | -36.2% | 13,441 | +147.1% | 0.01% | -38.5% |
| Q4 2015 | $553,000 | -22.7% | 5,439 | +35.7% | 0.01% | -38.1% |
| Q3 2015 | $715,000 | -28.2% | 4,008 | -10.6% | 0.02% | -25.0% |
| Q2 2015 | $996,000 | +61.2% | 4,485 | +44.1% | 0.03% | +55.6% |
| Q1 2015 | $618,000 | +70.2% | 3,113 | +22.8% | 0.02% | +63.6% |
| Q4 2014 | $363,000 | +6.1% | 2,535 | -2.8% | 0.01% | +10.0% |
| Q3 2014 | $342,000 | -29.0% | 2,608 | -31.7% | 0.01% | -41.2% |
| Q2 2014 | $482,000 | -18.7% | 3,819 | -15.0% | 0.02% | -22.7% |
| Q1 2014 | $593,000 | +107.3% | 4,495 | +84.8% | 0.02% | +83.3% |
| Q4 2013 | $286,000 | +26.5% | 2,432 | +12.5% | 0.01% | +20.0% |
| Q3 2013 | $226,000 | – | 2,162 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |